Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramses Forsyth

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Vaccines|November 13, 2020
Intratumoral Combinatorial Administration of CD1c (BDCA-1)<sup>+</sup> Myeloid Dendritic Cells Plus Ipilimumab and Avelumab in Combination with Intravenous Low-Dose Nivolumab in Patients with Advanced Solid Tumors: A Phase IB Clinical TrialJulia Katharina Schwarze, Gil Awada, Louise Cras, et al.
Computer Methods and Programs in Biomedicine|June 6, 2026
Perceptual quality assessment in digital pathology: Modeling diagnostic usability from expert opinionsTien Nguyen, Saeed Mahmoudpour, Guillaume E Courtoy, et al.
Bone|June 25, 2019
In situ cell cycle analysis in giant cell tumor of bone reveals patients with elevated risk of reduced progression-free survivalMate E Maros, Sven Schnaidt, Peter Balla, et al.
Journal of Clinical Pathology|December 24, 2010
Relationship between pathological features, HER2 protein expression and HER2 and CEP17 copy number in breast cancer: biological and methodological considerationsKathleen Lambein, Marleen Praet, Ramses Forsyth, et al.
Journal of Materials Science. Materials in Medicine|March 25, 2008
Biocompatibility and biodegradability of spider egg sac silkKris Gellynck, Peter Verdonk, Ramses Forsyth, et al.
International Journal of Cancer|November 19, 2020
Targeting USP13-mediated drug tolerance increases the efficacy of EGFR inhibition of mutant EGFR in non-small cell lung cancerPhilippe Giron, Carolien Eggermont, Amir Noeparast, et al.
Journal for Immunotherapy of Cancer|September 16, 2022
Intratumoral administration of CD1c (BDCA-1)<sup>+</sup> and CD141 (BDCA-3)<sup>+</sup> myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients: a phase I clinical trialJulia Katharina Schwarze, Jens Tijtgat, Gil Awada, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|September 8, 2015
Chondrogenic Priming at Reduced Cell Density Enhances Cartilage Adhesion of Equine Allogeneic MSCs - a Loading Sensitive Phenomenon in an Organ Culture Study with 180 ExplantsJan H Spaas, Sarah Y Broeckx, Koen Chiers, et al.
Laboratory Medicine|March 25, 2017
A Proposed Set of Metrics to Reduce Patient Safety Risk From Within the Anatomic Pathology LaboratoryPeter Banks, Richard Brown, Alex Laslowski, et al.
Journal of Neuropathology and Experimental Neurology|April 13, 2021
Novel Variant in COL4A1 Causes Extensive Prenatal Intracranial Hemorrhage and PorencephalyStefanie Brock, Alex Michotte, Elisa Doné, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Vaccines|November 13, 2020
Intratumoral Combinatorial Administration of CD1c (BDCA-1)<sup>+</sup> Myeloid Dendritic Cells Plus Ipilimumab and Avelumab in Combination with Intravenous Low-Dose Nivolumab in Patients with Advanced Solid Tumors: A Phase IB Clinical TrialJulia Katharina Schwarze, Gil Awada, Louise Cras, et al.
Computer Methods and Programs in Biomedicine|June 6, 2026
Perceptual quality assessment in digital pathology: Modeling diagnostic usability from expert opinionsTien Nguyen, Saeed Mahmoudpour, Guillaume E Courtoy, et al.
Bone|June 25, 2019
In situ cell cycle analysis in giant cell tumor of bone reveals patients with elevated risk of reduced progression-free survivalMate E Maros, Sven Schnaidt, Peter Balla, et al.
Journal of Clinical Pathology|December 24, 2010
Relationship between pathological features, HER2 protein expression and HER2 and CEP17 copy number in breast cancer: biological and methodological considerationsKathleen Lambein, Marleen Praet, Ramses Forsyth, et al.
Journal of Materials Science. Materials in Medicine|March 25, 2008
Biocompatibility and biodegradability of spider egg sac silkKris Gellynck, Peter Verdonk, Ramses Forsyth, et al.
International Journal of Cancer|November 19, 2020
Targeting USP13-mediated drug tolerance increases the efficacy of EGFR inhibition of mutant EGFR in non-small cell lung cancerPhilippe Giron, Carolien Eggermont, Amir Noeparast, et al.
Journal for Immunotherapy of Cancer|September 16, 2022
Intratumoral administration of CD1c (BDCA-1)<sup>+</sup> and CD141 (BDCA-3)<sup>+</sup> myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients: a phase I clinical trialJulia Katharina Schwarze, Jens Tijtgat, Gil Awada, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|September 8, 2015
Chondrogenic Priming at Reduced Cell Density Enhances Cartilage Adhesion of Equine Allogeneic MSCs - a Loading Sensitive Phenomenon in an Organ Culture Study with 180 ExplantsJan H Spaas, Sarah Y Broeckx, Koen Chiers, et al.
Laboratory Medicine|March 25, 2017
A Proposed Set of Metrics to Reduce Patient Safety Risk From Within the Anatomic Pathology LaboratoryPeter Banks, Richard Brown, Alex Laslowski, et al.
Journal of Neuropathology and Experimental Neurology|April 13, 2021
Novel Variant in COL4A1 Causes Extensive Prenatal Intracranial Hemorrhage and PorencephalyStefanie Brock, Alex Michotte, Elisa Doné, et al.
Pageof 5